X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (319) 319
humans (315) 315
viscosupplements - administration & dosage (216) 216
hyaluronic acid - administration & dosage (204) 204
female (201) 201
hyaluronic acid (186) 186
male (178) 178
middle aged (167) 167
viscosupplements - therapeutic use (125) 125
treatment outcome (121) 121
osteoarthritis (119) 119
injections, intra-articular (118) 118
surgery (118) 118
aged (113) 113
viscosupplements - adverse effects (113) 113
hyaluronic acid - therapeutic use (112) 112
adult (109) 109
hyaluronic acid - adverse effects (105) 105
orthopedics (79) 79
care and treatment (72) 72
viscosupplementation (72) 72
osteoarthritis, knee - drug therapy (71) 71
knee (66) 66
efficacy (58) 58
pain (56) 56
pain measurement (56) 56
prospective studies (56) 56
sodium hyaluronate (51) 51
double-blind (48) 48
injections (48) 48
follow-up studies (47) 47
knee osteoarthritis (47) 47
rheumatology (46) 46
dermatology (44) 44
management (44) 44
animals (41) 41
ophthalmology (41) 41
sport sciences (41) 41
medicine & public health (39) 39
aged, 80 and over (38) 38
abridged index medicus (37) 37
arthritis (37) 37
double-blind method (36) 36
injection (34) 34
hyaluronic-acid (31) 31
safety (30) 30
acid (29) 29
analysis (29) 29
osteoarthritis - drug therapy (29) 29
retrospective studies (28) 28
time factors (27) 27
viscosupplementation - methods (27) 27
young adult (26) 26
cosmetic techniques (23) 23
cosmetic techniques - adverse effects (23) 23
hylan g-f-20 (23) 23
patient satisfaction (23) 23
metaanalysis (22) 22
osteoarthritis, knee - therapy (22) 22
hyaluronan (21) 21
platelet-rich plasma (21) 21
health aspects (20) 20
hip (20) 20
hylan (20) 20
clinical trials (19) 19
hyaluronic acid - analogs & derivatives (19) 19
hyaluronic acid - pharmacology (19) 19
knee joint - drug effects (19) 19
multicenter (19) 19
randomized controlled trials as topic (19) 19
research (19) 19
trial (19) 19
comparative analysis (18) 18
corticosteroids (18) 18
skin aging - drug effects (18) 18
drug therapy, combination (17) 17
g-f 20 (17) 17
osteoarthritis, knee - physiopathology (17) 17
usage (17) 17
viscosupplements - pharmacology (17) 17
arthralgia - drug therapy (16) 16
pain - drug therapy (16) 16
range of motion, articular (16) 16
recovery of function (16) 16
therapy (16) 16
dentistry (15) 15
disease models, animal (15) 15
eye (15) 15
intraarticular injection (15) 15
molecular weight (15) 15
outcomes (15) 15
pilot projects (15) 15
randomized controlled-trial (15) 15
single-blind method (15) 15
adrenal cortex hormones - administration & dosage (14) 14
anti-inflammatory agents, non-steroidal - therapeutic use (14) 14
cartilage (14) 14
face (14) 14
gels (14) 14
medical colleges (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Ophthalmology, ISSN 0007-1161, 10/2012, Volume 96, Issue 10, pp. 1310 - 1315
Journal Article
Ophthalmology, ISSN 0161-6420, 2013, Volume 120, Issue 6, pp. 1158 - 1165
Journal Article
Journal Article
Dermatologic Surgery, ISSN 1076-0512, 12/2015, Volume 41 Suppl 1, pp. S354 - S357
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2016, Volume 163, pp. 122 - 131.e2
Purpose To compare the efficacies and safety profiles of 3% diquafosol and 0.1% sodium hyaluronate in patients with dry eye after cataract surgery. Design... 
Ophthalmology | OCULAR SURFACE | CORNEAL | WORKSHOP | POPULATION | HIGHER-ORDER ABERRATIONS | DISEASE | INS365 | OPHTHALMOLOGY | MODEL | SECRETION | HYALURONIC-ACID | Staining and Labeling - methods | Polyphosphates - adverse effects | Prospective Studies | Phacoemulsification - adverse effects | Humans | Middle Aged | Purinergic P2Y Receptor Agonists - adverse effects | Viscosupplements - adverse effects | Male | Polyphosphates - administration & dosage | Dry Eye Syndromes - diagnosis | Uracil Nucleotides - adverse effects | Viscosupplements - administration & dosage | Ophthalmic Solutions | Female | Surveys and Questionnaires | Uracil Nucleotides - administration & dosage | Fluorescent Dyes - administration & dosage | Hyaluronic Acid - adverse effects | Hyaluronic Acid - administration & dosage | Purinergic P2Y Receptor Agonists - administration & dosage | Dry Eye Syndromes - drug therapy | Tears - chemistry | Lissamine Green Dyes - administration & dosage | Visual Acuity | Fluorescein - administration & dosage | Aged | Tears - physiology | Lens Implantation, Intraocular | Administration, Topical | Dry Eye Syndromes - etiology | Eye | Medical colleges | Cataract | Care and treatment | Surgery | Ophthalmic drugs | Hyaluronic acid | Fluorescein | Cataracts | Sodium | Clinical trials | Eye diseases | Inflammation | FDA approval | Patient satisfaction | Eye surgery | Eye care products | Quality of life | Index Medicus | Abridged Index Medicus
Journal Article
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 10/2015, Volume 96, pp. 388 - 395
Viscosupplementation (VS) is a therapy for osteoarthrosis (OA) consisting of repetitive intra-articular injections of hyaluronic acid (HA). It is known to be... 
Rabbit | Osteoarthrosis | Anterior cruciate ligament transection | Chitosan | Hyaluronic acid | Antioxidant | Viscosupplementation | KNEE | DEFECTS | RESORPTION | OSTEOPOROSIS | HYDROGEL | ARTICULAR-CARTILAGE | BONE REPAIR | DEGRADATION | PHARMACOLOGY & PHARMACY | SCAFFOLD | Bone and Bones - pathology | Hyaluronic Acid - therapeutic use | Antioxidants - chemistry | Hydrogels | Cartilage - pathology | Viscosupplements - adverse effects | Synovial Membrane - pathology | Delayed-Action Preparations - chemistry | Knee Joint - ultrastructure | Male | Cartilage - drug effects | Synovial Membrane - drug effects | Bone and Bones - drug effects | Resorcinols - adverse effects | Synovial Membrane - ultrastructure | Knee Joint - pathology | Viscosupplements - therapeutic use | Bone and Bones - metabolism | Chitosan - therapeutic use | Chitosan - adverse effects | Acetylation | Hyaluronic Acid - adverse effects | Cartilage - ultrastructure | Disease Models, Animal | Knee Joint - metabolism | Viscosupplements - chemistry | Rabbits | Knee Joint - drug effects | Hyaluronic Acid - chemistry | Random Allocation | Cartilage - metabolism | Resorcinols - therapeutic use | Synovial Membrane - metabolism | Chemistry, Pharmaceutical | Antioxidants - therapeutic use | Animals | Chitosan - chemistry | Delayed-Action Preparations - adverse effects | Resorcinols - chemistry | Chitosan - pharmacokinetics | Osteoarthritis, Knee - pathology | Delayed-Action Preparations - therapeutic use | Drug Liberation | Antioxidants - adverse effects | Bone and Bones - ultrastructure | Osteoarthritis, Knee - drug therapy | Osteoarthritis, Knee - metabolism | Index Medicus
Journal Article
Nature Reviews Rheumatology, ISSN 1759-4790, 11/2012, Volume 8, Issue 11, pp. 635 - 636
The latest in a series of meta-analyses of trials assessing viscosupplementation for knee osteoarthritis is the first to raise concerns about its safety.... 
HYALURONIC-ACID | RHEUMATOLOGY | Meta-Analysis as Topic | Injections, Intra-Articular - adverse effects | Viscosupplementation - adverse effects | Humans | Viscosupplements - adverse effects | Hyaluronic Acid - adverse effects | Osteoarthritis, Knee - drug therapy | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article